Pull down to go back
OpenAI Launches GPT-Rosalind, an AI Model Trained for Drug Development and Medical Breakthroughs

OpenAI Launches GPT-Rosalind, an AI Model Trained for Drug Development and Medical Breakthroughs

OpenAI公布生命科學語言模型GPT-Rosalind進軍藥物開發

OpenAI unveiled GPT-Rosalind last week, a specialized language model trained for the life sciences industry. The model is designed to accelerate drug development and advance medical therapies by helping researchers analyze biological data and discover new treatments faster. This could potentially speed up the process of getting new medicines to patients.